CXCR2-driven NE cells are critical for the tumor microenvironment by providing a survival niche for AR+ luminal cells; consequently, combination of CXCR2 inhibition (Figure 5B) and AR targeting effectively inhibited lineage plasticity and NE transition in mouse xenograft models [34]. The gene discussed is AR; the disease is neoplasm.